The present invention is directed to pyrrolidin-3-yl derivative compounds which are inhibitors of the beta-secretase enzyme and that are useful in the treatment of diseases in which the beta-secretase enzyme is involved, such as Alzheimer's disease. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the treatment of such diseases in which the beta-secretase enzyme is involved.
本发明涉及
吡咯烷基衍
生物化合物,它们是β-分泌酶酶的
抑制剂,并且在治疗涉及β-分泌酶酶的疾病,如阿尔茨海默病方面有用。本发明还涉及包含这些化合物的制药组合物,以及在治疗涉及β-分泌酶酶的疾病中使用这些化合物和组合物。